XML 21 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 4 - Income Taxes
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
4.
            Income taxes
 
During the
first
nine
months of
2017,
we recorded a non-cash charge to our valuation allowance of
$141,000
increasing our valuation allowance against deferred tax assets to
$12.7
million at
September 30, 2017.
The primary assets covered by this valuation allowance are net operating losses, which are approximately
$21.8
million at
September 30, 2017.
In the prior year
nine
months, we utilized
$19.7
million of our net operating loss carry-forward against taxable income resulting primarily from our surrender of corporate-owned life insurance policies. The premiums paid and the growth in surrender value of these policies were excludable from taxable income over the life of these policies when held until death of the covered lives, but this growth, net of premiums paid, became taxable when we surrendered the policies. The aggregate impact of the surrender of these policies in the
first
quarter of last year was the creation of
$24.0
million in taxable income. The income tax benefit in the current
three
and
nine
month periods was due to state income tax adjustments. In the prior year, the income tax expense associated with the surrender of the corporate-owned life insurance policies was recognized in full during the prior year
first
quarter and was largely the result of federal alternative minimum tax which limits our ability to offset income generated during the period with net operating carry-forwards, and, to a lesser extent, the impact of surrendering these policies have on state income taxes.
 
We maintain a valuation allowance against deferred tax assets that currently exceed our deferred tax liabilities.
The primary assets covered by this valuation allowance are net operating loss carry-forwards. The valuation allowance was calculated in accordance with the provisions of ASC
740,
Income Taxes
, which requires an assessment of both positive and negative evidence when measuring the need for a valuation allowance. Our results over the most recent
three
-year period were heavily affected by our business restructuring activities. Our cumulative loss, excluding income from the Continued Dumping and Subsidy Offset Act, in the most recent
three
-year period, in our view, represented sufficient negative evidence to require a valuation allowance under the provisions of ASC
740,
Income Taxes
. We intend to maintain a valuation allowance, resulting in
no
deferred tax asset balance being recognized, until sufficient positive evidence exists to support its reversal. Should we determine that we will
not
be able to realize all or part of our deferred tax asset in the future, an adjustment to the deferred tax asset will be charged to income in the period such determination is made.
 
Our effective tax rate
s for the current
three
and
nine
month periods were
9.5%
and
4.7%
due to state income tax adjustments. The effective tax rate in the prior year
three
and
nine
month periods were negative
6.1%
and negative
16.0%,
respectively, driven by the impact of the alternative minimum tax and state related taxes on the surrender of corporate owned life insurance policies. The major reconciling items between our effective income tax rate and the federal statutory rate are the change in our valuation allowance and, in the prior year period, the cash surrender value on life insurance policies.